Journal of the New Zealand Medical Association Vol 132 | No 1491 | 8 March 2019 Where are we going with cancer treatment in New Zealand? New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease Developing a regional Lifespan of New Zealand Advancing transgender cancer service; lessons Second World War veterans healthcare teaching in from the Waitemata Cancer from one large cemetery: the Aotearoa/New Zealand Patient Experience Survey case for a national-level study Publication Information published by the New Zealand Medical Association NZMJ Editor NZMA Chair Professor Frank Frizelle Dr Kate Baddock NZMJ Production Editor NZMA Communications Manager Rory Stewart Diana Wolken Other enquiries to: NZMA To contribute to the NZMJ, fi rst read: PO Box 156 www.nzma.org.nz/journal/contribute The Terrace Wellington 6140 © NZMA 2019 Phone: (04) 472 4741 To subscribe to the NZMJ, email
[email protected] Subscription to the New Zealand Medical Journal is free and automatic to NZMA members. Private subscription is available to institutions, to people who are not medical practitioners, and to medical practitioners who live outside New Zealand. Subscription rates are below. All access to the NZMJ is by login and password, but IP access is available to some subscribers. Read our Conditions of access for subscribers for further information www.nzma.org.nz/journal/subscribe/conditions-of-access If you are a member or a subscriber and have not yet received your login and password, or wish to receive email alerts, please email:
[email protected] The NZMA also publishes the NZMJ Digest.